Damora Therapeutics, Inc. short interest in 2026
In 2026, Damora Therapeutics, Inc.'s disclosed short interest ran from 12.76% of shares outstanding on 15 Jan 2026 to 7.67% on 15 Sep 2026, a change of -5.09 percentage points. The year's high was 24.49% on 27 Feb 2026 and its low 6.69% on 31 Aug 2026, averaging 12.43% across 8 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.57 days on 14 Aug 2026. Full history: Damora Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 12.76% (15 Jan 2026)
- End of year
- 7.67% (15 Sep 2026)
- Change
- -5.09 pp
- High
- 24.49% (27 Feb 2026)
- Low
- 6.69% (31 Aug 2026)
- Average
- 12.43%
- Highest days to cover
- 13.57 (14 Aug 2026)
- SEC filings marked
- 4
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 12.76% | 6.28 | |
| 30 Jan 2026 | 11.19% | 4.56 | |
| 13 Feb 2026 | 20.87% | 1.00 | |
| 27 Feb 2026 | 24.49% | 1.13 | |
| 31 Jul 2026 | 8.11% | 11.71 | results (8-K), 10-K filed, 10-Q filed |
| 14 Aug 2026 | 7.68% | 13.57 | 10-Q filed |
| 31 Aug 2026 | 6.69% | 13.27 | |
| 15 Sep 2026 | 7.67% | 8.56 |
See also: Damora Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.